Last reviewed · How we verify
NCT03816267
Salbutamol Administration by Nebulizer Versus Metered Dose Inhaler With Spacer in Asthma in Children
Phase 3 trial testing Nebulizer in Bronchial Asthma in 60 participants. Completed in 31 March 2019.
15 March 2019
Quick facts
| Lead sponsor | Suez Canal University |
|---|---|
| Phase | Phase 3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 15 May 2018 |
| Primary completion | 15 March 2019 |
| Estimated completion | 31 March 2019 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Nebulizer
- Salbutamol (salbutamol) — full drug profile →
- Metered dose inhaler and spacer
Conditions studied
- Bronchial Asthma — all drugs for Bronchial Asthma →
Sponsor
Suez Canal University
Who can join
Adults 2 to 14, any sex, with Bronchial Asthma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Asthma is a problem that affects many children and affects their physical health in addition to having a social and financial burden on individuals, families and healthcare systems. In our pediatric emergency department, nebulizers are still used for the management of asthma and, with the poor resources of families, they have no option of treatment at home. In this study, the investigators will compare the effectiveness of treatment through nebulizer versus metered dose inhaler and spacer in children with an acute asthmatic attack seeking medical care at the Pediatric Emergency Department of Suez Canal University Hospital.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03816267
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Nebulizer
Trials testing the same drug.
- NCT07048262 — Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NC · Phase 2 · recruiting
- NCT05651958 — Effects of Pranayama Breathing Technique in Patients With Chronic Obstructive Pulmonary Disease · NA · completed
- NCT04064684 — Inhaled Steroids for the Treatment of Early Pediatric Acute Respiratory Distress Syndrome · Phase 2 · terminated
Other recruiting trials for Bronchial Asthma
Currently open trials in the same condition.
- NCT07183657 — Adherence to Inhaled Therapy - a Globally Overlooked Problem in Patients With Chronic Obstructive Pulmonary Disease and · NA · recruiting
- NCT07054034 — Study of MG-ZG122 Humanized Monoclonal Antibody in Asthma Subjects · Phase 2 · active not recruiting
- NCT07060079 — The Use of Entropy to Assess Sleep Disordered Breathing in Chronic Respiratory Disease · recruiting
- NCT06721247 — Oral Intake of Mg in Controlled Asthmatic Patients · Phase 2, PHASE3 · active not recruiting
- NCT06852911 — FeNO Detection in Asthma Diagnosis: A New Technology Approach · NA · recruiting
Other Suez Canal University trials
Trials by the same sponsor.
- NCT07263893 — Inter Flex Three Dimensional Plate in Management of Mandibular Fracture RCT · NA · recruiting
- NCT07280533 — Accuracy of Virtual Surgical Planning Versus Traditional Technique in Zygomaticomaxillary Fracture Reduction · NA · not yet recruiting
- NCT07291791 — tDCS for Pain Modulation in Knee Osteoarthritis · NA · active not recruiting
- NCT07262086 — Clinical Evaluation of Wear Resistance and Bioactivity of Self Cured Bioactive Resin Composite · NA · enrolling by invitation
- NCT07125846 — Efficacy of Bioactive Glass vs. Xenograft in Maxillary Sinus Augmentation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03816267 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Suez Canal University
- Last refreshed: 4 April 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03816267.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing